explore -WSS

explore

author：knowledge 2025-10-02 22:15:28 - browse：8697

Teladoc website -- health tech coverage from STAT — Adobe

Virtual care company Teladoc has a new chief executive officer following the abrupt departure of its longtime leader in April.

Chuck Divita, who took on the role Monday, previously led the commercial markets business at GuideWell, the parent company of health plan Florida Blue. He was also previously chief financial officer at FPIC Insurance Group, a publicly traded insurance company focused on medical liability.

Board chair David Snow said in a release that Divita’s health care experience and tenure at a public company made him an attractive candidate. Divita has also joined Teladoc’s board of directors.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： FDA approves world's first CRISPR

WSS

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

STAT letters to the editor on burnt

Americans' trust in science, scientist continues decline: Report

Study on Amgen’s bispecific immunotherapy produces positive data

Study on Amgen’s bispecific immunotherapy produces positive data

Roche to buy Carmot Therapeutics, developer of obesity drugs

Wikipedia

explore

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

BioMarin wins approval for gene therapy to treat hemophilia A

Teach medical students about patients with intellectual disabilities

Drug repurposing or repositioning? The language matters

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Tori Bowie and the unacceptable rates of Black maternal death

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

STAT Readout: Friday, Oct. 20 biotech updates

Cancer drug shortages should be causing more outrage

Supreme Court wrestles with OxyContin maker's bankruptcy deal

hotspot

J&J lung cancer data amount to new salvo against AstraZeneca

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

Congenital heart disease patients face new threat of heart failure

Chemotherapy shortages won’t get better under Biden’s latest plan

Teach medical students about patients with intellectual disabilities

Merck, Daiichi strike cancer drug pact worth up to $22 billion

focus

entertainment

explore

hotspot